[go: up one dir, main page]

WO2002026824A3 - Nouveau recepteur humain couple a la proteine g, hgprbmy5, hautement exprime dans les tissus du cerveau et des ovaires - Google Patents

Nouveau recepteur humain couple a la proteine g, hgprbmy5, hautement exprime dans les tissus du cerveau et des ovaires Download PDF

Info

Publication number
WO2002026824A3
WO2002026824A3 PCT/US2001/030365 US0130365W WO0226824A3 WO 2002026824 A3 WO2002026824 A3 WO 2002026824A3 US 0130365 W US0130365 W US 0130365W WO 0226824 A3 WO0226824 A3 WO 0226824A3
Authority
WO
WIPO (PCT)
Prior art keywords
brain
coupled receptor
protein coupled
hgprbmy5
novel human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/030365
Other languages
English (en)
Other versions
WO2002026824A2 (fr
Inventor
John N Feder
Gabe Mintier
Chandra Sekar Ramanathan
Donald R Hawken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to AU2001294841A priority Critical patent/AU2001294841A1/en
Publication of WO2002026824A2 publication Critical patent/WO2002026824A2/fr
Publication of WO2002026824A3 publication Critical patent/WO2002026824A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention porte sur un récepteur humain de la protéine G récemment découvert et sur le polynucléotide le codant. L'invention porte également sur des vecteurs d'expression, des cellules hôtes, des agonistes, des antagonistes, des molécules antisens et des anticorps associés au polynucléotide et/ou au polypeptide de cette invention. De plus, l'invention porte sur des procédés de traitement, de diagnostic, prévention et d'analyse de pathologies associées à une prolifération cellulaire aberrante, à des états neurologiques et des maladies ou troubles liés au cerveau, aux ovaires, au thymus ou aux poumons.
PCT/US2001/030365 2000-09-27 2001-09-26 Nouveau recepteur humain couple a la proteine g, hgprbmy5, hautement exprime dans les tissus du cerveau et des ovaires Ceased WO2002026824A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001294841A AU2001294841A1 (en) 2000-09-27 2001-09-26 A novel human g-protein coupled receptor, hgprbmy5, expressed highly in brain and ovarian tissues

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US23571300P 2000-09-27 2000-09-27
US60/235,713 2000-09-27
US26178101P 2001-01-16 2001-01-16
US60/261,781 2001-01-16
US30660501P 2001-07-19 2001-07-19
US60/306,605 2001-07-19
US31043601P 2001-08-03 2001-08-03
US60/310,436 2001-08-03

Publications (2)

Publication Number Publication Date
WO2002026824A2 WO2002026824A2 (fr) 2002-04-04
WO2002026824A3 true WO2002026824A3 (fr) 2002-10-17

Family

ID=27499808

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/030365 Ceased WO2002026824A2 (fr) 2000-09-27 2001-09-26 Nouveau recepteur humain couple a la proteine g, hgprbmy5, hautement exprime dans les tissus du cerveau et des ovaires

Country Status (2)

Country Link
AU (1) AU2001294841A1 (fr)
WO (1) WO2002026824A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082650A1 (en) * 2001-08-30 2003-05-01 Baylor College Of Medicine Great gene and protein
JP2004041172A (ja) * 2002-03-15 2004-02-12 Japan Tobacco Inc 新規受容体ポリペプチド及びそれをコードするｄｎａ
WO2003081256A2 (fr) * 2002-03-22 2003-10-02 Bayer Healthcare Ag Diagnostics et therapeutique pour des maladies associees au recepteur 21 orphelin couple a la proteine g humain (gpr21)
AU2003227427A1 (en) * 2002-04-19 2003-11-03 K. K. Dnaform Novel proteins and dnas encoding the same
US7189539B2 (en) * 2003-11-25 2007-03-13 Bristol-Myers Squibb Company Polynucleotide encoding a human relaxin receptor, HGPRBMY5v1

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048921A1 (fr) * 1998-03-26 1999-09-30 The Board Of Trustees Of The Leland Stanford Junior University Nouveaux recepteurs de mammiferes couples a la proteine g et presentant des zones de repetition riches en leucine
WO2000015793A2 (fr) * 1998-09-17 2000-03-23 Incyte Pharmaceuticals, Inc. Proteines gpcr humaines
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2002004640A1 (fr) * 2000-07-07 2002-01-17 Takeda Chemical Industries, Ltd. Nouvelle proteine du type recepteur couple aux proteines g et adn correspondant
WO2002014489A2 (fr) * 2000-08-10 2002-02-21 Amgen, Inc. Molecules du recepteur 8 couple a la protenie g contenant des repetitions riches en leucines, et utilisations associees

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048921A1 (fr) * 1998-03-26 1999-09-30 The Board Of Trustees Of The Leland Stanford Junior University Nouveaux recepteurs de mammiferes couples a la proteine g et presentant des zones de repetition riches en leucine
WO2000015793A2 (fr) * 1998-09-17 2000-03-23 Incyte Pharmaceuticals, Inc. Proteines gpcr humaines
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2002004640A1 (fr) * 2000-07-07 2002-01-17 Takeda Chemical Industries, Ltd. Nouvelle proteine du type recepteur couple aux proteines g et adn correspondant
WO2002014489A2 (fr) * 2000-08-10 2002-02-21 Amgen, Inc. Molecules du recepteur 8 couple a la protenie g contenant des repetitions riches en leucines, et utilisations associees

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 200223, Derwent World Patents Index; Class B04, AN 2002-179706, XP002204698 *

Also Published As

Publication number Publication date
AU2001294841A1 (en) 2002-04-08
WO2002026824A2 (fr) 2002-04-04

Similar Documents

Publication Publication Date Title
WO2001055328A8 (fr) Acides nucleiques, proteines et anticorps
WO2001090304A3 (fr) Acides nucleiques, proteines et anticorps
WO2001054472A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055306A3 (fr) Acides nucleiques, proteines, et anticorps
WO2002086076A3 (fr) Polynucleotides et polypeptides associes au chemin nf-kb
WO2000056405A3 (fr) Recepteur tr2 du facteur de necrose tumorale chez l'homme
WO2003046147A3 (fr) Nouveau recepteur couple a la proteine g humaine, hgprbmy31, variants et procedes d'utilisation de ce dernier
WO2002083856A3 (fr) Polynucleotides codant deux nouveaux recepteurs couples aux proteines g, hgprbmy28 et hgprbmy29, et leurs variants d'epissage
WO2001055326A3 (fr) Acides nucleiques, proteines et anticorps
WO2002026824A3 (fr) Nouveau recepteur humain couple a la proteine g, hgprbmy5, hautement exprime dans les tissus du cerveau et des ovaires
WO2004039940A3 (fr) Polynucleotide codant pour des recepteurs couples aux proteines g, et leurs variantes d'epissage
WO2002040670A3 (fr) Hgprbmy8 : nouveau recepteur couple a la proteine g humaine exprime en grande quantite dans le cerveau
WO2005048951A3 (fr) Hgprbmy8, nouveau recepteur couple a la proteine g humaine, s'exprimant fortement dans l'encephale
WO2001055440A8 (fr) Acides nucleiques, proteines et anticorps
WO2001042285A3 (fr) Matrice extracellulaire et molecules d'adherence cellulaire
WO2002026823A3 (fr) Nouveau recepteur hgprbmy7, couple a la proteine g humaine, a expression elevee dans la moelle epiniere
WO2002026987A3 (fr) Hgprbmy6, nouveau recepteur couple a la proteine g humaine et fortement exprime dans l'intestin grele
WO2003087332A3 (fr) Nouveaux polynucleotides codant le polypeptide kinase citron humain, bmsnkc 0020/0021
WO2005003299A3 (fr) Polynucleotides codant de nouvelles proteines de liaison au guanylate (gbp)
WO2004048549A3 (fr) Proteines interagissant avec le recepteur dep-1, proteine tyrosine phosphatase, et procedes associes
WO2003016478A3 (fr) Polynucleotides codant pour les recepteurs couples aux proteines g et methodes d'utilisation
WO2003050256A3 (fr) Nouveau recepteur couple aux proteines g humain, hgprbmy34, ses variantes, et procedes d'utilisation associes
WO2001055167A8 (fr) Acides nucleiques, proteines et anticorps
WO2002046414A3 (fr) Hgprbmy23, nouveau recepteur d'origine humaine couple aux proteines g exprime fortement dans le rein
WO2003062393A3 (fr) Nouveau recepteur couple a la proteine g humaine, ses variantes et ses methodes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP